Noryln L Aquino, | |
4020 Folker St, Anchorage, AK 99508-5321 | |
(907) 563-1000 | |
Not Available |
Full Name | Noryln L Aquino |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 4020 Folker St, Anchorage, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104431667 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Noryln L Aquino, 4020 Folker St, Anchorage, AK 99508-5321 Ph: (907) 563-1000 | Noryln L Aquino, 4020 Folker St, Anchorage, AK 99508-5321 Ph: (907) 563-1000 |
News Archive
A study conducted in the UK has examined attitudes towards vaccination protecting against COVID-19 and highlighted some of the main drivers of willingness or unwillingness to be immunized.
Rhythm, a biotechnology company developing peptide therapeutics for metabolic diseases, today announced a study of obese primates treated with RM-493 showing a reversal of obesity and insulin resistance, and improvement in both heart rate and blood pressure. RM-493 is a novel peptide agonist targeting the melanocortin 4 receptor (MC4R) that is a clinical candidate for the treatment of obesity and diabetes.
The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regaring the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.
Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments.
Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sleep-wake regulation currently being studied for the potential treatment of multiple sleep-wake disorders.
› Verified 2 days ago
Mr. Duncan R Brooks, MS, LPC. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 E International Airport Rd Ste 100, Anchorage, AK 99518 Phone: 907-570-6382 Fax: 888-972-3679 | |
Carolyn Michaud, OTD OTR/L Counselor Medicare: Not Enrolled in Medicare Practice Location: 4325 Laurel St Ste 102, Anchorage, AK 99508 Phone: 907-569-5660 | |
Patricia Quinn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 741 Sesame St Ste 1b, Anchorage, AK 99503 Phone: 907-406-2642 | |
Mrs. Rebecca Ann Shestakov, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6952 Cutty Sark St, Anchorage, AK 99502 Phone: 907-982-5562 | |
Parinita Shetty, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7440 Creekside Center Dr, Anchorage, AK 99504 Phone: 907-279-9640 | |
Tau Vaaia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1709 Bragaw St, Anchorage, AK 99508 Phone: 907-562-5340 | |
Katie Ogin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2600 Cordova St, Anchorage, AK 99503 Phone: 907-279-9640 |